Integrating traditional medicine with network pharmacology for Alzheimer's treatment
A progressive neurological disease with a high global prevalence, Alzheimer's disease (AD) is characterized by memory impairment. Due to their primary focus on either a single signaling route or a particular molecular target, current treatment methods have shown limited success. An overview of...
Saved in:
| Main Authors: | Sunil Kumar Kadiri, Prashant Tiwari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Health Sciences Review |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772632025000157 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01) -
Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
by: Mohammed Alrouji, et al.
Published: (2025-06-01) -
Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals
by: Henry Gilreath Stephenson, et al.
Published: (2025-01-01) -
Novel targets for the treatment and prevention of Alzheimer's disease in the European population, inspiration from amyloid beta and tau protein
by: Xifeng Wang, et al.
Published: (2024-10-01) -
Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
by: Alexandra Paget‐Blanc, et al.
Published: (2025-04-01)